Hepatitis C Antibody
Diagnostic TestPatients who received a blood test to screen for the Hepatitis C virus.
NCT Number: NCT03316313
The purpose of this study is to determine whether patient education improves Hepatitis C screening in the primary care setting.
Looking for future studies?
Notify Me50 year–71 year
All sexes
Observational
Hepatitis C is a chronic, asymptomatic infection that progresses to liver cirrhosis and cancer in the later stages if left untreated. The Centers for Disease Control (CDC) recommends a one-time screening for high risk birth cohort between the years 1945-1965. Prior studies have evaluated methods to improve screening for hepatitis c with focus on increasing awareness in health professionals. Targets included nursing staff and electronic medical records. This study targets providing patients with education resources to see if screening rates improve.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients who received a blood test to screen for the Hepatitis C virus.
Time frame: June 2016 to October 2016.
Change from baseline in number of patients from high-risk birth cohort screened for Hepatitis C during intervention period.
New York Institute of Technology
Other
Prospective Cohort Study: Hepatitis C Screening in the Primary Care Setting
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03935906
Blood-Borne Infections, Communicable Diseases
Melbourne, Australia
View Trial DetailsNCT00004850
Blood-Borne Infections, Communicable Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05208697
Blood-Borne Infections, Communicable Diseases
Fort Lauderdale, Florida, United States
View Trial DetailsNCT03222531
Blood-Borne Infections, Cardiac Transplant
Pittsburgh, Pennsylvania, United States
View Trial Details